Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study
Latest Information Update: 03 Nov 2017
Price :
$35 *
At a glance
- Drugs Vortioxetine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Takeda
- 01 Sep 2015 Pooled analysis results (NCT00761306, NCT00694304, NCT00707980, NCT01323478 and NCT01152996) presented at the 28th Annual Congress of the European College of Neuropsychopharmacology.
- 01 Sep 2015 Pooled subgroup analysis results ((NCT00761306, NCT00694304, NCT00707980, NCT01323478 and NCT01152996)) presented at the 28th Annual Congress of the European College of Neuropsychopharmacology.
- 09 Mar 2015 New trial record